|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Noncash lease expense | |||||
| Stock compensation expense | |||||
| Stock issued for interest expense | |||||
| Restricted common stock issued for compensation | |||||
| Accretion of debt discount | |||||
| Derecognition expense on conversion of convertible debt | |||||
| Changes in fair value of derivative liability | |||||
| Loss on sale of Ryvyl EU | |||||
| Impairment of goodwill | |||||
| Impairment of intangible assets | |||||
| Restructuring charges | |||||
| Loss on sale of property and equipment | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid and other current assets | |||||
| Cash due from gateways, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued and other current liabilities | |||||
| Accrued interest | |||||
| Payment processing liabilities, net | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of property and equipment | |||||
| Sky Financial & Intelligence asset acquisition | |||||
| Purchases of property and equipment | |||||
| Logicquest Technology acquisition | |||||
| Capitalized software development costs | |||||
| Purchase of intangibles | |||||
| Cash transferred in connection with the sale of Ryvyl EU | |||||
| Net cash used in investing activities | |||||
| Deposit on acquisitions | |||||
| Cash flows from financing activities: | |||||
| Treasury stock purchases | |||||
| Proceeds from stock option exercises | |||||
| Repayments of convertible debt | |||||
| Repayments of long-term debt | |||||
| Tax withholdings related to net settlement of equity awards | |||||
| Proceeds from short-term note payable | |||||
| Proceeds from issuance of common stock in public offering, net of issuance costs | |||||
| Proceeds from common warrant exercises | |||||
| Proceeds from issuance of Series C convertible preferred stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Restricted cash acquired from Transact Europe | |||||
| Effect of exchange rates in cash and restricted cash | |||||
| Net (decrease) increase in cash and restricted cash | |||||
| Cash and restricted cash – beginning of period | |||||
| Cash and restricted cash – end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...